VMAT2 inhibitors for the treatment of hyperkinetic movement disorders
Jessa Koch, Wei‐Xing Shi, Khashayar Dashtipour
Topics & Concepts
TetrabenazineTardive dyskinesiaChoreaMovement disordersHuntington's diseaseVesicular monoamine transporterDyskinesiaMedicinePharmacologyMonoamine neurotransmitterDiseaseDopaminePsychiatryInternal medicineSchizophrenia (object-oriented programming)Parkinson's diseaseSerotoninReceptorGenetic Neurodegenerative DiseasesNeurological disorders and treatmentsParkinson's Disease Mechanisms and Treatments